All In Biotech

Free tool

FAERS Monitor: Prialt

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021060 or its brand name (Prialt, Ziconotide Acetate). Reports on generic versions are filed under their own applications.

Reports

2,435

Serious

1,162

48% of reports

Hospitalization

560

Death reported

121

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pain362
  • device issue313
  • off label use302
  • drug ineffective241
  • confusional state205
  • nausea205
  • hallucination168
  • dizziness157
  • headache136
  • hallucination, auditory133
  • memory impairment104
  • fall101
  • vomiting99
  • somnolence95
  • drug withdrawal syndrome91

Reports by year received

View as table
YearReports
200575
200697
2007102
200828
200930
201037
201150
201266
201361
201496
2015118
2016392
2017304
2018268
2019211
202026
2021125
202282
202383
202470
202574
202639

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,724 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hallucination, auditorySignal13372.961.89,289
device issueSignal31330.227.38,830
hallucinationSignal16819.316.72,900
confusional stateSignal20511.09.61,860
drug withdrawal syndromeSignal919.07.3638
memory impairmentSignal1046.55.4486
painSignal3625.14.61,222
somnolenceSignal954.13.3220
off label useSignal3023.02.7412
dizzinessSignal1572.72.3173
fallSignal1012.62.2101
nauseaSignal2052.22.0144
headache1361.91.656
vomiting991.81.536
drug ineffective2411.61.454

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.